GEN Exclusives

More »

GEN Poll

More »
Nov 26, 2012

Female Sexual Dysfunction Drugs

While men have had Viagra, Cialis, and Levitra to address their sexual dysfunction issues for about a decade, finding a solution for women’s woes has been more complicated. The market for female sexual dysfunction (FSD) drugs is believed larger than the market for male sexual dysfunction treatments, yet despite this no FDA-approved treatments for FSD exist—though several drug developers are closer than ever to changing that. Once approved, how much of a rise do you think they’ll get in sales compared to ED drugs?

Do you think future FSD drugs have the potential to be as successful as ED drugs have been?

Yes
 
  60.0%
No
 
  40.0%

Related content

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

Be sure to take the GEN Poll

Using CRISPRs to Tame GMOs

With more climate-induced droughts and insect infestations on the horizon do you think technologies like CRISPR will change a lot of people’s minds about GMOs, including genetically engineered foods?

More »